Is long-term prediction in membranous nephropathy (MGN) better than the weatherman's forecast capacity?

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 8, 2012, Pages 1203-1205

  Cattran, Daniel C ^a   Kim, Joseph ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 MICROGLOBULIN; ANGIOTENSIN ANTAGONIST; BETA 2 MICROGLOBULIN; CREATININE; IMMUNOSUPPRESSIVE AGENT;

AREA UNDER THE CURVE; ATHEROSCLEROSIS; CHRONIC KIDNEY FAILURE; COMORBIDITY; CONSERVATIVE TREATMENT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE ACTIVITY; DISEASE COURSE; EDITORIAL; FALSE POSITIVE RESULT; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY INJURY; LONG TERM CARE; MEMBRANOUS GLOMERULONEPHRITIS; OBESITY; PHENOTYPE; PREDICTION AND FORECASTING; PROTEINURIA; RECEIVER OPERATING CHARACTERISTIC; REMISSION; THROMBOEMBOLISM;

ALPHA-GLOBULINS; BETA 2-MICROGLOBULIN; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MALE; PROTEINURIA;

EID: 84864807109     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06600712     Document Type: Editorial

References (23)

1. Pollak VE, Rosen S, Pirani CL, Muehrcke RC, Kark RM: Natural history of lipoid nephrosis and of membranous glomerulonephritis. Ann Intern Med 69: 1171-1196, 1968
2. Barbour SJ, Greenwald A, Djurdjev O, Levin A, Hladunewich MA, Nachman PH, Hogan SL, Cattran DC, Reich HN: Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int 81: 190-195, 2012
3. Bello AK, Hemmelgarn B, Lloyd A, James MT, Manns BJ, Klarenbach S, Tonelli M; Alberta Kidney Disease Network: Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes. Clin J AmSoc Nephrol 6: 1418-1426, 2011
4. Polanco N, Gutiérrez E, Covarsi{dotless}́ A, Ariza F, Carreño A, Vigil A, Baltar J, Fernández-Fresnedo G, Marti{dotless}́n C, Pons S, Lorenzo D, Bernis C, Arrizabalaga P, Fernández-Juá rez G, Barrio V, Sierra M, Castellanos I, Espinosa M, Rivera F, Oliet A, Fernández-Vega F, Praga M; Grupo de Estudio de las Enfermedades Glomerulares de la Sociedad Españ ola de Nefrologi{dotless}́a: Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol 21: 697-704, 2010
5. Polanco N, Gutiérrez E, Rivera F, Castellanos I, Baltar J, Lorenzo D, Praga M; Grupo de Estudio de las Enfermedades Glomerulares de la Sociedad Española de Nefrologi{dotless}́a (GLOSEN): Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment. Nephrol Dial Transplant 27: 231-234, 2012
6. Pei Y, Cattran D, Greenwood C: Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 42: 960-966, 1992
7. Cattran DC, Reich HN, Kim SJ, Troyanov S: Have we changed the outcome in membranous nephropathy? A propensity study on the role of immunosuppressive therapy. Clin J Am Soc Nephrol 6: 1591-1598, 2011
8. van den Brand JAJG, Hofstra JM, Wetzels JFM: Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 7: 1242-1248, 2012
9. Reichert LJ, Koene RA, Wetzels JF: Prognostic factors in idiopathic membranous nephropathy. Am J Kidney Dis 31: 1-11, 1998
10. Branten AJ, du Buf-Vereijken PW, Klasen IS, Bosch FH, FeithGW, Hollander DA, Wetzels JF: Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: A validation study. J Am Soc Nephrol 16: 169-174, 2005
11. Hofstra JM, Deegens JK, Willems HL, Wetzels JF: Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy. Nephrol Dial Transplant 23: 2546-2551, 2008
12. van den Brand JAJG, Hofstra JM, Wetzels JFM: Low-molecularweight proteins as prognostic markers in idiopathic membranous nephropathy. Clin J AmSoc Nephrol 6: 2846-2853, 2011
13. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC; Toronto Glomerulonephritis Registry Group: Idiopathic membranous nephropathy: Definition and relevance of a partial remission. Kidney Int 66: 1199-1205, 2004
14. Pencina MJ, D'Agostino RB, Vasan RS: Statistical methods for assessment of added usefulness of new biomarkers. Clin Chem Lab Med 48: 1703-1711, 2010
15. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW: Assessing the performance of prediction models: A framework for traditional and novel measures. Epidemiology 21: 128-138, 2010
16. Cattran DC, Pei Y, Greenwood CM, Ponticelli C, Passerini P, Honkanen E: Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int 51: 901-907, 1997
17. Troyanov S, Roasio L, Pandes M, Herzenberg AM, Cattran DC: Renal pathology in idiopathic membranous nephropathy: A new perspective. Kidney Int 69: 1641-1648, 2006
18. Zent R, Nagai R, Cattran DC: Idiopathic membranous nephropathy in the elderly: A comparative study. Am J Kidney Dis 29: 200-206, 1997
19. du Buf-Vereijken PW, Wetzels JF: Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency. Nephrol Dial Transplant 21: 389-396, 2006
20. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11-21, 2009
21. Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Kottgen A, Dragomirescu L, Voinescu C, Patel N, Pearce K, Hubank M, Stephens HA, Laundy V, Padmanabhan S, Zawadzka A, Hofstra JM, Coenen MJ, den Heijer M, Kiemeney LA, Bacq-DaianD, Stengel B, Powis SH, Brenchley P, Feehally J, Rees AJ, DebiecH, Wetzels JF, Ronco P, Mathieson PW, Kleta R: Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 364: 616-626, 2011
22. Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ: Antiphospholipase A receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6: 1286-1291, 2011
23. Beck LH, Fervenza FC, Beck DM, Bonegio RGB, Malik FA, Erickson SB, Cosio FG, Cattran DC, Salant DJ: Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. AmSoc Nephrol 22: 1543-1550, 2011